Mutation detail:
| Mutation site | V1239A |
| Virus | Measles virus |
Mutation level  |
Amino acid Level |
| Gene/protein/region type | L |
| Gene ID | 1489802 |
| Country | - |
| Mutation type |
nonsynonymous mutation |
| Genotype/subtype/clade | - |
| Sample |
cell line |
| Variants | - |
| Viral reference sequence | K01711.1 |
| Drug/antibody/vaccine | AS-136A resistant |
| Transmissibility |
- |
| Transmission mechanism | - |
| Pathogenicity |
- |
| Pathogenicity mechanism | - |
| Immune escape mutation | - |
| Immune escape mechanism | - |
| RT-PCR primers probes | - |
Protein detail:
| Protein name | Large Polymerase Protein |
| Uniprot protein ID | P12576 |
| Protein length | 2183 amino acids |
| Protein description | The viral polymerase (an RNA-dependent RNA polymerase, RdRp) or large protein is coded by the L gene. It catalyzes RNA synthesis, polymerization, capping, polymerization, methylation and polyadenylation. The negative sense RNA is transcribed directly into mRNA without forming any DNA intermediate. |
Literature information:
| Pubmed ID | 19528268 |
| Clinical information | No |
| Disease | - |
| Published year | 2009 |
| Journal | Antimicrobial Agents and Chemotherapy |
| Title | Target analysis of the experimental measles therapeutic AS-136A |
| Author | Jeong-Joong Yoon,Stefanie A Krumm,J Maina Ndungu,Vanessa Hoffman,Bettina Bankamp |
| Evidence | FIG. 4 |